Tanvex received marketing authorization from Health Canada Oct.17,2021 Jul.01,2024 Tanvex received BLA approval from FDA Read More Jul.08,2024 TX05 BLA resubmisson Read More May.16,2023 Tanvex BioPharma Enters Exclusive Distribution Agreement for Nypozi (filgrastim) in Canada Read More